2-oxoquinoline compounds and pharmaceutical uses thereof
AssigneeJapan Tobacco Inc.
InventorsTakashi Inaba, Tetsudo Kaya, Hiroyuki Iwamura
Life of this patent
Estimating the term…
Abstract
A 2-oxoquinoline compound or its pharmaceutically acceptable salt of general formula [I]: (wherein each symbol in the formula is as determined in the description), and its pharmaceutical use. The compound [I] of the present invention and its pharmaceutically acceptable salts selectively act on cannabinoid receptors, particularly on peripheral type cannabinoid receptors, and have fewer side effects on the central nervous system, having great immunosuppressive action, anti-inflammatory action or antiallergic action. Therefore, these compounds are useful as cannabinoid receptors (particularly peripheral type cannabinoid receptors) modulator, immunosuppressants, anti-inflammatory agents, and antiallergic agents.
Claims7
A cannabinoid receptor modulator comprising, as an active ingredient, 7-methoxy-2-oxo-8-pentyloxy-1,2-dihydroquinoline-3-carboxylic acid (3,4-methylenedioxybenzyl)amide, or a pharmaceutically acceptable salt thereof.
7-Methoxy-2-oxo-8-pentyloxy-1,2-dihydroquinoline-3-carboxylic acid (3,4-methylenedioxybenzyl)amide, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.